Search Results 631-640 of 29980 for Pulmonary

1. Oatd-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness, safety, tolerability, PD, and PK of OATD-01 in the treatment of patients with active pulmonary ...

2. Kefir may improve gut health of patients in the ICU - Mayo Clinic

   Pulmonary, Critical Care, and Sleep Medicine · Referrals · News · Videos · Physicians · Continuing EducationExternal Link · Clinical Trials. Kefir may improve ...

3. Atrial septal defect (ASD) - Symptoms and causes - Mayo Clinic

   Pulmonary hypertension can cause permanent lung damage. This complication, called Eisenmenger syndrome, most often occurs over many years. It sometimes happens ...

4. Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of bexotegrast (PLN-74809) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF) ...

5. Home sleep apnea test simplifies diagnosing obstructive sleep apnea - Mayo Clinic

   Morgenthaler, M.D., Pulmonary and Critical Care Medicine at Mayo Clinic in Rochester, Minnesota. "One reason may be that there are too many barriers to ...

6. Noonan syndrome - Symptoms and causes - Mayo Clinic

   ... pulmonary artery. Pulmonary valve stenosis is the most common heart problem seen with Noonan syndrome. It may occur with or without other heart problems ...

7. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment.

8. Michael J. Krowka, M.D. - Mayo Clinic Faculty Profiles

   Hepatopulmonary syndrome (HPS). This is a liver-induced pulmonary vasodilation problem causing severely low oxygen levels in the blood. No medication can ...

9. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   The purpose of this study is to determine if Simtuzumab (GS-6624) is safe and effective in treating Idiopathic Pulmonary Fibrosis. Participation eligibility.

10. Kaiser G. Lim, M.D. - Mayo Clinic Faculty Profiles

    Pulmonary physiology in health and disease. Exercise physiology. Pulmonary function testing. The management of severe persistent asthma. The interaction of the ...